MedTrace Logo

Rapid Detection of Staphylococcus Aureus in Burn Patients

NCT01140269 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 218

Last updated 2023-08-04

No results posted yet for this study

Summary

The purpose of this study is to determine if rapid early detection of the bacteria causing sepsis in burn patients improves patient outcomes.

Conditions

Interventions

OTHER

PCR test

PCR samples will test for Staphylococcus aureus (including MRSA) from wound swab and positive blood culture samples to augment treatment decisions. Serial PCR testing will follow after positive results to catalog pathogen loads over the course of treatment in a blinded fashion.

Sponsors & Collaborators

  • U.S. Army Medical Research and Development Command

    collaborator FED

  • American Burn Association

    lead OTHER

Principal Investigators

  • Nam Tran, PhD · University of California, Davis

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-05-30
Primary Completion
2019-09-29
Completion
2019-09-29

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01140269 on ClinicalTrials.gov